Artemis Medicare Services Ltd. (ARTEMISMED) Share Price Hits New 52-Week High
- August 5, 2026
- Posted by: Harsh Piplani
- Category: News
Artemis Medicare Services Ltd. Share Price reached a new 52-week high of Rs 312, marking a 2.04% increase today. The company’s market cap stands at Rs 4,783.22 crore.
Artemis Medicare Services Ltd. Share Price has reached a fresh 52-week high of Rs 312, reflecting a 2.04% rise from the previous close of Rs 301.95. The stock opened at Rs 302.5 and experienced a day low of the same, indicating strong upward momentum. With a market capitalisation of Rs 4,783.22 crore, Artemis Medicare is capturing investor attention in the healthcare sector.
Artemis Medicare Services Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 308.1 |
| Previous Close | Rs 301.95 |
| Today's Change | +Rs 6.15 (+2.04%) |
| Day Open | Rs 302.5 |
| Fresh 52-Week High | Rs 312 |
| Day Low | Rs 302.5 |
| Current Volume | 9,800 |
| Turnover | Rs 0.3 crore |
| Market Capitalisation | Rs 4,783.22 crore |
Artemis Medicare Services Ltd. (ARTEMISMED) traded at Rs 308.1. versus the previous close of Rs 301.95, a rise of 2.04%. The stock opened at Rs 302.5, reached Rs 312, touched Rs 302.5. Reported volume was 9,800.
Today’s trading session saw Artemis Medicare Services Ltd. Share Price climb to a new 52-week high of Rs 312. The stock opened at Rs 302.5 and reached a day low of the same, before surging to its peak. The current price of Rs 308.1 represents a 2.04% increase from the previous close. Trading volume stood at 9,800 shares, with a turnover of Rs 0.3 crore, indicating moderate market participation. This price movement highlights the stock’s positive momentum, setting the stage for further analysis of its fundamentals.
Artemis Medicare Services Ltd. (ARTEMISMED) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,783.22 crore |
| P/E Ratio | 30.21x |
| P/B Ratio | 0.44x |
| ROE | -2.89% |
| ROCE | -0.26% |
Artemis Medicare Services Ltd. was valued at a P/E ratio of 30.21x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 30.21x |
| Benchmark Median P/E | 21.71x |
| Benchmark Average P/E | 71.67x |
| Benchmark P/E Range | 0x to 3,385.56x |
| Company P/B Ratio | 0.44x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.75% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 4,783.22 crore |
| Benchmark Median Market Cap | Rs 136.63 crore |
Artemis Medicare Services Ltd. (ARTEMISMED) is classified under sector: Healthcare.
Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 30.21x, which is above the benchmark median of 21.71x, a difference of +39.15%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Artemis Medicare Services Ltd. (ARTEMISMED) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. Artemis Medicare Services Ltd. (ARTEMISMED) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,945.17 | 30.21 | 0.44 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,652.68 | 39.86 | 8.11 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,608.51 | 63.2 | 10 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,457.9 | 32.25 | 6.65 | -2.6 | 16.92 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,451.51 | 164.6 | 3.04 | 13.9 | 12.97 |
Artemis Medicare Services Ltd. (ARTEMISMED) has a P/E ratio of 30.21x compared with the displayed peer median of 39.86x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Artemis Medicare Services Ltd. (ARTEMISMED) has a market capitalisation of Rs 4,783.22 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Artemis Medicare Services Ltd.
- Artemis Medicare Services Ltd. Share Price reached a new 52-week high of Rs 312.
- Moderate trading volume with a turnover of Rs 0.3 crore.
- Higher P/E ratio compared to sector median, indicating relative valuation.
- Potential undervaluation suggested by low P/B ratio.
- Negative ROE and ROCE highlight profitability challenges.
About Artemis Medicare Services Ltd.
Artemis Medicare Services Ltd. operates in the healthcare sector, providing a range of medical services. The company is known for its hospital and healthcare services, catering to a diverse patient base. With a focus on quality care and advanced medical technology, Artemis Medicare aims to enhance patient outcomes and expand its market presence. Despite its current financial challenges, the company continues to be a significant player in the healthcare industry.
Track Artemis Medicare Services Ltd. Share Price on Univest
Use Artemis Medicare Services Ltd. (ARTEMISMED) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Artemis Medicare Services Ltd. Share Price, technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights on Univest for comprehensive analysis and informed decision-making.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Artemis Medicare Services Ltd.?
Ans. The current share price of Artemis Medicare Services Ltd. is Rs 308.1, marking a 2.04% increase from the previous close of Rs 301.95. The stock moved 2.04% during the session.
What is the 52-week high of Artemis Medicare Services Ltd.?
Ans. Artemis Medicare Services Ltd. has reached a new 52-week high of Rs 312, reflecting strong market interest and positive price momentum. The stock moved 2.04% during the session. The intraday range extended from Rs 302.5 to Rs 312.
How does Artemis Medicare's P/E ratio compare to the sector?
Ans. Artemis Medicare's P/E ratio of 30.21 is above the sector median of 21.71, indicating a relatively higher valuation compared to its sector peers. The company trades at a P/E ratio of 30.21x.
What is the market capitalisation of Artemis Medicare Services Ltd.?
Ans. The market capitalisation of Artemis Medicare Services Ltd. is Rs 4,783.22 crore, positioning it as a significant player in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 30.21x.
How does Artemis Medicare's P/B ratio compare to the sector?
Ans. Artemis Medicare's P/B ratio of 0.44 is significantly lower than the sector median of 1.9, suggesting a potential undervaluation relative to its book value. The company trades at a P/E ratio of 30.21x.
What are the ROE and ROCE of Artemis Medicare Services Ltd.?
Ans. Artemis Medicare Services Ltd. has a negative ROE of -2.89% and ROCE of -0.26%, indicating challenges in profitability and capital efficiency. ROE stands at -2.89%. ROCE stands at -0.26%. The relevant peer median ROE is 10.75%.
How does Artemis Medicare compare to its peers?
Ans. Artemis Medicare's P/E ratio is comparable to Dishman Carbogen Amcis Ltd., but its P/B ratio is lower than most peers, indicating potential undervaluation. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.
